Doug Hampton

Dragonfly Therapeutics présentera les résultats de la phase 1 de la monothérapie DF1001 à l’occasion du congrès annuel de l’ASCO 2023

by

Une présentation orale intitulée « Phase 1/2 Study of DF1001, an Immune Modulating TriNKET® Targeting HER2, in Patients with Advanced Solid Tumors: Phase 1 DF1001 Monotherapy Dose Escalation Results » sera présentée par Howard Safran, directeur médical, lors de la session ASCO Developmental Therapeutics – Immunotherapy le 4 juin. WALTHAM, Mass., 3 juin 2023 /PRNewswire/ — Dragonfly Therapeutics, Inc, une société … Read more

Risks of listeriosis: many batches of Saint-Nectaire AOP recalled in supermarkets

by

the essential Many batches of Saint-Nectaire cheese, sold throughout France, have been recalled. These batches of cheese are likely to contain listeria monocytogenes. Be careful with your pieces of Saint-Nectaire AOP. On May 31, the Rappel Conso site, several batches of cheeses were recalled from stores. Marketed under the label “Saint Nectaire AOP farmer – … Read more

Sanctuary Cannabis Opens 19th Medical Cannabis Dispensary in Boynton Beach, Florida

by

BOYNTON BEACH, Fla, June 3, 2023 /PRNewswire/ — Sanctuary Cannabis, a trusted provider of high-quality medical cannabis products, is excited to announce the grand opening of its 19th medical cannabis dispensary in Boynton Beach, Florida. The new dispensary is located at 710 N Federal Hwy, Boynton Beach, FL 33435, United States. The grand opening event … Read more

Precigen Announces Positive Phase 1 Data for Off-the-Shelf PRGN-2009 AdenoVerse™ Immunotherapy Alone and in Combination with an Investigational Checkpoint Inhibitor in Patients with Recurrent/Metastatic HPV-associated Cancers

by

–  PRGN-2009 combined with an investigational checkpoint inhibitor resulted in a 30% ORR in patients with heavily pre-treated HPV-associated cancers that were naïve or resistant to checkpoint blockade with prolonged duration of responses – –  Recurrent/metastatic HPV-associated cancers (cervical, anal, oropharyngeal, etc.) are incurable by current therapies – –  PRGN-2009 was safe and well-tolerated with only Grade … Read more

When athletes trust ultra-tech but bogus objects

by

(ETX Daily Up) – Can Technology Help Athletes Win? If the importance of good equipment is no longer to be demonstrated, particularly at the professional level, questions remain with regard to objects with (so-called) developed technology. The latest case? This famous patch worn by tennis player Novak Djokovic at Roland Garros. During his victory against … Read more

A promising treatment for early-stage breast cancer

by

(AFP) – A treatment tested against early-stage breast cancer has been shown to reduce the risk of recurrence by 25%, according to the results of a large clinical trial published on Friday, representing hope for many patients. These preliminary results were unveiled at the largest annual conference of cancer specialists, hosted by the American Society … Read more

Health: what is cupping, this cupping therapy practiced by Karim Benzema?

by

the essential Coming from traditional Chinese and Arabic medicine, cupping therapy is on the rise, especially among some high-level athletes. But what are we talking about? A few days ago, footballer Karim Benzema appeared on his Instagram account lying on his stomach, seven suction cups clutching his back. Before him, in 2016, swimming champion Michael … Read more

Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023

by

Initial data showed promising signs of efficacy, including a 47.1% ORR in patients with resistant/refractory gastric cancer expressing Claudin 18.2, with a well-tolerated safety profile Elevation Oncology on track to initiate Phase 1 clinical trial in the US in the second half of 2023 NEW YORK, June 3, 2023 /PRNewswire/ — Elevation Oncology, Inc. (Nasdaq: … Read more

Study by Didier Raoult on hydroxychloroquine: the Medicines Agency will take legal action

by

the essential According to the ANSM, Didier Raoult’s work on treatment with hydroxychloroquine “should have received a favorable opinion from a committee for the protection of persons and authorization” from him to be implemented. The National Medicines Safety Agency (ANSM) announced to the Parisian that she was preparing “to take legal action” concerning the last … Read more